ENvue Medical, Inc. Revenue
ENvue Medical, Inc. (FEED) reported Revenue of $239.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-17
- ENvue Medical, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $239.00K, a 51.62% decline year-over-year.
- ENvue Medical, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $653.00K, a 36.29% decline year-over-year.
- ENvue Medical, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $312.00K, a 29.73% decline year-over-year.
- ENvue Medical, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $722.00K, a 92.02% increase year-over-year.
- ENvue Medical, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $2.55M, a 0.20% decline from fiscal 2024.
- ENvue Medical, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $2.56M, a 12.05% increase from fiscal 2023.
- ENvue Medical, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $2.28M, a 203.59% increase from fiscal 2022.
- ENvue Medical, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $752.00K, a 55.63% decline from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $239.00K 10-Q · filed 2026-08-17 | $892.00K 10-Q · filed 2026-08-17 | $1.20M derived: sum of 3 quarters · filed 2026-08-17 | $1.93M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $653.00K 10-Q · filed 2026-05-18 | $965.00K derived: sum of 2 quarters · filed 2026-05-18 | $1.69M derived: sum of 3 quarters · filed 2026-05-18 | $2.18M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $312.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $1.03M derived: sum of 2 quarters · filed 2026-04-15 | $1.53M derived: sum of 3 quarters · filed 2026-08-17 | $2.55M 10-K · filed 2026-04-15 |
| 2025-09-30 | $722.00K 10-Q · filed 2025-11-14 | $1.22M derived: sum of 2 quarters · filed 2026-08-17 | $2.24M 10-Q · filed 2025-11-14 | $2.69M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $494.00K 10-Q · filed 2026-08-17 | $1.52M 10-Q · filed 2026-08-17 | $1.96M derived: sum of 3 quarters · filed 2026-08-17 | $2.34M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $1.02M 10-Q · filed 2026-05-18 | $1.47M derived: sum of 2 quarters · filed 2026-05-18 | $1.84M derived: sum of 3 quarters · filed 2026-05-18 | $2.66M derived: sum of 4 quarters · filed 2026-05-18 |
| 2024-12-31 | $444.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $820.00K derived: sum of 2 quarters · filed 2026-04-15 | $1.64M derived: sum of 3 quarters · filed 2026-04-15 | $2.56M 10-K · filed 2026-04-15 |
| 2024-09-30 | $376.00K 10-Q · filed 2025-11-14 | $1.19M derived: sum of 2 quarters · filed 2025-11-14 | $2.11M 10-Q · filed 2025-11-14 | $3.29M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $817.00K 10-Q · filed 2025-08-19 | $1.74M 10-Q · filed 2025-08-19 | $2.92M derived: sum of 3 quarters · filed 2025-08-19 | $3.37M derived: sum of 4 quarters · filed 2025-08-19 |
| 2024-03-31 | $921.00K 10-Q · filed 2025-05-20 | $2.10M derived: sum of 2 quarters · filed 2025-05-20 | $2.56M derived: sum of 3 quarters · filed 2025-05-20 | $2.85M derived: sum of 4 quarters · filed 2025-05-20 |
| 2023-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.64M derived: sum of 2 quarters · filed 2025-03-31 | $1.93M derived: sum of 3 quarters · filed 2025-03-31 | $2.28M 10-K · filed 2025-03-31 |
| 2023-09-30 | $458.00K 10-Q · filed 2024-11-14 | $752.00K derived: sum of 2 quarters · filed 2024-11-14 | $1.11M 10-Q · filed 2024-11-14 | $1.00M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $294.00K 10-Q · filed 2024-08-14 | $648.00K 10-Q · filed 2024-08-14 | $546.00K derived: sum of 3 quarters · filed 2024-08-14 | $643.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $354.00K 10-Q · filed 2024-05-15 | $252.00K derived: sum of 2 quarters · filed 2024-05-15 | $349.00K derived: sum of 3 quarters · filed 2024-05-15 | $834.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-08 | -$5.00K derived: sum of 2 quarters · filed 2024-04-08 | $480.00K derived: sum of 3 quarters · filed 2024-04-08 | $752.00K 10-K · filed 2024-04-08 |
| 2022-09-30 | $97.00K 10-Q · filed 2023-11-13 | $582.00K derived: sum of 2 quarters · filed 2023-11-13 | $854.00K 10-Q · filed 2023-11-13 | $1.63M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $485.00K 10-Q · filed 2023-08-11 | $757.00K 10-Q · filed 2023-08-11 | $1.53M derived: sum of 3 quarters · filed 2023-08-11 | $2.03M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $272.00K 10-Q · filed 2023-05-15 | $1.05M derived: sum of 2 quarters · filed 2023-05-15 | $1.55M derived: sum of 3 quarters · filed 2023-05-15 | $1.86M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $775.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $1.27M derived: sum of 2 quarters · filed 2023-04-17 | $1.59M derived: sum of 3 quarters · filed 2023-04-17 | $1.70M 10-K · filed 2023-04-17 |
| 2021-09-30 | $499.00K 10-Q · filed 2022-11-14 | $817.00K derived: sum of 2 quarters · filed 2022-11-14 | $920.00K 10-Q · filed 2022-11-14 | $1.01M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $318.00K 10-Q · filed 2022-08-15 | $421.00K 10-Q · filed 2022-08-15 | $511.00K derived: sum of 3 quarters · filed 2022-08-15 | $661.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $103.00K 10-Q · filed 2022-05-16 | $193.00K derived: sum of 2 quarters · filed 2022-05-16 | $343.00K derived: sum of 3 quarters · filed 2022-05-16 | $612.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-15 | $240.00K derived: sum of 2 quarters · filed 2022-04-15 | $509.00K derived: sum of 3 quarters · filed 2022-04-15 | $623.00K 10-K · filed 2022-04-15 |
| 2020-09-30 | $150.00K 10-Q · filed 2021-11-15 | $419.00K derived: sum of 2 quarters · filed 2021-11-15 | $533.00K 10-Q · filed 2021-11-15 | $620.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $269.00K 10-Q · filed 2021-08-16 | $383.00K 10-Q · filed 2021-08-16 | $470.00K derived: sum of 3 quarters · filed 2021-08-16 | $571.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $114.00K 10-Q · filed 2021-05-24 | $201.00K derived: sum of 2 quarters · filed 2021-05-24 | $302.00K derived: sum of 3 quarters · filed 2021-05-24 | $565.00K derived: sum of 4 quarters · filed 2021-05-24 |
| 2019-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-15 | $188.00K derived: sum of 2 quarters · filed 2021-04-15 | $451.00K derived: sum of 3 quarters · filed 2021-04-15 | $530.00K 10-K · filed 2021-04-15 |
| 2019-09-30 | $101.00K 10-Q · filed 2020-11-16 | $364.00K derived: sum of 2 quarters · filed 2020-11-16 | $443.00K 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $263.00K 10-Q/A · filed 2020-08-24 | $342.00K 10-Q/A · filed 2020-08-24 | ||
| 2019-03-31 | $79.00K 10-Q · filed 2020-07-06 | |||
| 2018-12-31 | $318.00K 10-K · filed 2020-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| LogicMark, Inc. (LGMK) | United States | $0.000B | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |